Sublobar resection for metachronous stage I second primary non-small cell lung cancer: A single-centre experience

被引:0
|
作者
Yotsumoto, Takuma [1 ,2 ]
Fujimori, Sakashi [1 ]
Suzuki, Souichiro [1 ]
Kikunaga, Shinichiro [1 ]
Niitsuma, Toru [1 ]
机构
[1] Toranomon Gen Hosp, Dept Thorac Surg, Resp Ctr, 2-2-2 Toranomon, Tokyo 1058470, Japan
[2] 2-2-2 Toranomon, Tokyo 1058470, Japan
关键词
Postoperative surveillance; second primary lung cancer; segmentectomy; wedge resection; SURGICAL-TREATMENT; RECURRENCE; LOBECTOMY;
D O I
10.4103/lungindia.lungindia_8_23
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: More patients are developing second primary lung cancer (SPLC). This study aimed to evaluate the impact of the extent of SPLC resection on outcomes.Material and Methods: We retrospectively investigated 1,895 patients with lung cancer who underwent pulmonary resection from 2011 to 2018. SPLC was diagnosed using the criteria of Martini and Melamed. Patients with pathological stage I SPLC who underwent lobectomy for first primary lung cancer (FPLC) were included in the study. Outcomes and clinical factors that could affect survival were evaluated.Results: Fifty-four patients were eligible for the study. Lobectomy, segmentectomy, or wedge resection was performed for 10, 32, and 12 patients, respectively. Neither overall nor relapse-free survival was significantly different based on the extent of resection for stage I SPLC. Multivariate analysis revealed that interval between FPLC and SPLC of less than 5 years was an independent risk factors for worse relapse-free survival after SPLC resection (interval: hazard ratio, 0.28; P = 0.048). The median interval from prior resection to secondary resection was 68 months.Conclusions: Sublobar resection might be a realistic option for stage I SPLC. To realize early detection of SPLC that can undergo radical sublobar resection, the surveillance period after prior resection of FPLC is worth reconsidering.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
  • [11] Sublobar resection for early-stage non-small cell lung cancer and current advances with immunotherapy in multimodality treatment of resectable non-small cell lung cancer
    Agrafiotis, Apostolos C.
    Hendriks, Jeroen M. H.
    Van Schil, Paul E.
    AME SURGICAL JOURNAL, 2024, 4
  • [12] Identification of Stage I Non-small Cell Lung Cancer Patients at High Risk for Local Recurrence Following Sublobar Resection
    Varlotto, John M.
    Medford-Davis, Laura N.
    Recht, Abram
    Flickinger, John
    Yao, Nengliang
    Hess, Clayton
    Reed, Michael F.
    Toth, Jennifer
    Zander, Dani S.
    DeCamp, Malcolm M.
    CHEST, 2013, 143 (05) : 1365 - 1377
  • [13] The Role of Sublobar Resection for the Surgical Treatment of Non-Small Cell Lung Cancer
    Behinaein, Parnia
    Treffalls, John
    Hutchings, Hollis
    Okereke, Ikenna C.
    CURRENT ONCOLOGY, 2023, 30 (07) : 7019 - 7030
  • [14] Lobectomy versus sublobar resection in patients with non-small cell lung cancer: a systematic review
    Divisi, Duilio
    De Vico, Andrea
    Zaccagna, Gino
    Crisci, Roberto
    JOURNAL OF THORACIC DISEASE, 2020, 12 (06) : 3357 - 3362
  • [15] Meta-analysis of Lobectomy and Sublobar Resection for Stage I Non-small Cell Lung Cancer
    Li, Jialong
    Wang, Yan
    Li, Jue
    Cao, Shangqi
    Che, Guowei
    CLINICAL LUNG CANCER, 2022, 23 (03) : 208 - 213
  • [16] Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease
    Tsutani, Yasuhiro
    Mimura, Takeshi
    Kai, Yuichiro
    Ito, Masaoki
    Misumi, Keizo
    Miyata, Yoshihiro
    Okada, Morihito
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (03) : 1089 - +
  • [17] Accurate Selection of Sublobar Resection for Small Non-small Cell Lung Cancer
    Motono, Nozomu
    Mizoguchi, Takaki
    Ishikawa, Masahito
    Iwai, Shun
    Iijima, Yoshihito
    Uramoto, Hidetaka
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 811 - 822
  • [18] Sublobar Versus Lobar Resection for Stage I Non-Small Cell Lung Cancer Alice's Evidence
    Takagi, Hisato
    Matsui, Masafumi
    Umemoto, Takuya
    CANCER JOURNAL, 2011, 17 (04) : 264 - 265
  • [19] Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?
    Akamine, Takaki
    Wakasu, Sho
    Matsubara, Taichi
    Yamaguchi, Masafumi
    Yamazaki, Koji
    Hamatake, Motoharu
    Kometani, Takuro
    Kinoshita, Fumihiko
    Kohno, Mikihiro
    Shimokawa, Mototsugu
    Takenaka, Tomoyoshi
    Yoshizumi, Tomoharu
    ANNALS OF SURGICAL ONCOLOGY, 2024, : 4161 - 4172
  • [20] Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection
    Yendamuri, Sai
    Dhillon, Samjot Singh
    Groman, Adrienne
    Dy, Grace
    Dexter, Elisabeth
    Picone, Anthony
    Nwogu, Chukwumere
    Demmy, Todd
    Hennon, Mark
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (01) : 394 - 402